Duaklir® Genuair® (aclidinium/formoterol fumarate dihydrate)
Duaklir® Genuair® (aclidinium/formoterol fumarate dihydrate) is a maintenance bronchodilator for relieving symptoms in adult patients with chronic obstructive pulmonary disease (COPD)
Duaklir® Genuair®▼ is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD)1.
Duaklir® Genuair® is a dry powder inhaler combining the long-acting antimuscarinic agent (LAMA) aclidinium and the long-acting beta agonist (LABA) formoterol. Each delivered dose contains the equivalent of 340 µg of aclidinium and 11.8 µg of formoterol fumarate dihydrate1
Dosing and Administration1
The recommended dose is one inhalation of Duaklir® Genuair® twice daily
No dose adjustments are required in elderly patients or patients with renal or hepatic impairment1
How to use the Genuair® inhaler
The Duaklir® Genuair® inhaler has a simple feedback mechanism to ensure correct inhalation, the colour changes from green to red1. In one study 97% (140/144) of inhalations with Genuair® inhaler were successful across 48 patients with moderate to severe COPD2.
*Successful inhalation was defined as an inhalation sufficient to activate the inhaler trigger and produce a colour change from green to red in the control window2
To order a placebo device, please contact Medical Information on 0800 783 0033 or e-mail firstname.lastname@example.org
A dose indicator shows approximately how many doses are left in the inhaler to the nearest ten doses. When nearly empty, a red band is displayed, indicating that a replacement inhaler should be obtained1
For a demonstration video on how to use the Genuair® inhaler click the video player below